Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
RSLS logo

RSLS

NSC
ReShape Lifesciences Inc.
HealthcareMedical Devices
Watchlists:
Last updated: Monday 7th July 2025
2.37
-0.05 (-2.07%)
Prev Close:2.42
Open:2.4
Bid:2.35
Ask:2.45
52 Week Range
2.23
414.70
Volume:2,749,950
Mkt Cap:2 M
Price Target
$2.73
+15.2%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Scores

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

RSLS - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Accrued Preferred Stock Dividends3 M
Acquisition Expense1000000.0
Depreciation And Amortization22000.0121000.0330000.0232000.015000.0400000.0-242000.0
Gain On Sale Of PPE33000.0-529000.0-486000.0
General And Administrative Expense7 M10 M31 M33 M15 M22 M14 M-357000.0-229000.0-262000.0
Gross Profit Margin (profit Margin After CGS)5 M6 M7 M8 M6 M9 M443000.0235884.0355184.0166953.0
Impairment Of Capital Assets800000.019 M31 M1 M7 M14 M
Interest Expense Non Operating113000.0832000.02 M3874.04 M939182.0
Minority Interests5 M
Misc Other Special Charges674000.04 M11000.0-2 M-8 M-1 M-11000.0-5 M4 M3 M
Net Income (loss)-7 M-11 M-46 M-63 M-22 M-24 M-35 M-30 M-23 M-25 M
Net Income Common Stockholders-7 M-11 M-46 M-63 M-22 M-74 M-38 M-30 M-23 M-25 M
Net Income Continuous Operations-7 M-11 M-46 M-63 M-22 M-24 M-35 M-30 M-23 M-25 M
Net Income Discontinuous Operations-46 M-3 M
Net Non Operating Interest Income Expense14000.026000.0-113000.0-832000.0-2 M-451000.0-12000.0-2808.0-4 M-937363.0
Non Recurring Operation Expense2 M
Normalized Income-6 M-2 M
Operating Income-8 M-15 M-46 M-58 M-12 M-16 M-25 M-28 M-23 M-28 M
Operating Income Before Depreciation (EBITDA)-7 M-11 M-44 M-61 M-18 M-72 M-38 M-33 M-17 M-24 M
Operating Expense13 M21 M53 M66 M19 M34 M-39 M-28 M-23 M-28 M
Other Gand A7 M10 M31 M33 M15 M22 M14 M-357000.0-229000.0-262000.0
Other Impairment Of Capital Assets36000.0777000.019 M31 M1 M
Other Operating Expenses300000.0300000.0700000.066 M300000.0-643000.0
Otherunder Preferred Stock Dividend3 M
Preferred Stock Dividends3 M
Promotion And Advertising700000.02 M7 M3 M500000.0800000.0
Rent And Landing Fees14 M-357000.0-229000.0-262000.0
Research Expense2 M2 M3 M2 M3 M3 M6 M5 M5 M8 M
Restructring And Mn A Income1 M-13792.0
Salaries And Wages184000.0766000.02 M12 M1 M3 M145000.0-4 M
Selling And Marketing Expense3 M8 M7 M3 M500000.0800000.05 M23 M18 M20 M
Selling Expense5 M23 M18 M20 M
Total Income Available For Interest Expense (EBIT)-7 M-11 M-46 M-63 M-20 M-75 M-39 M-33 M-19 M-25 M
Total Revenues8 M9 M11 M14 M11 M15 M607000.0569160.0786660.0292000.0
Total Expenses16 M24 M58 M71 M24 M40 M-39 M-29 M-24 M-28 M
Total Revenue8 M9 M11 M14 M11 M15 M607000.0569160.0786660.0292000.0
Amord33000.02 M2 M2 M2 M-198000.0
Avgshs20622.04107.0292.0170.031.07.00.05.00.02.0
Avgshsdt20622.04107.0292.0170.031.07.00.05.00.02.0
Basiceps-345.75-2769.5-3 M-362500.0-678600.0-9 M
Basicepscont-345.75-2769.5-157905.0-362500.0-678600.0-9 M
Cor3 M3 M4 M5 M5 M6 M-164000.0-333276.0-431476.0-125047.0
Depamor22000.0121000.0330000.0232000.015000.0400000.0-242000.0
Dileps-345.75-2769.5-3 M-362500.0-678600.0-9 M-89 M-7 M-82 M-9 M
Dilepscont-345.75-2769.5-157905.0-362500.0
Intinc14000.026000.0-113000.0-832000.0-2 M-451000.0-12000.0-2808.05837.01819.0
Netincdisc-7 M-11 M-46 M-63 M-22 M-24 M-35 M-30 M-23 M-25 M
Othincexp-638000.0-3 M-19 M2 M8 M2 M11000.05 M-4 M-3 M
Pretaxinc-7 M-11 M-47 M-63 M-22 M-75 M-39 M-33 M-23 M-25 M
Resdev2 M2 M3 M2 M3 M3 M6 M5 M5 M8 M
Restruct1 M-13792.0
Sga10 M18 M31 M33 M15 M22 M19 M23 M18 M20 M
Shsout11 M16177.01826.0257.028.025.04.014.03.012.0
Specincchg-800000.0-19 M-31 M-1 M-8 M-14 M
Taxprov39000.052000.0-380000.0-274000.0-181000.0-893000.0-3 M-2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader